Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8248776 | 8486001 | I | 8248776-X | 20120326 | 20120331 | EXP | PHHY2012CA026908 | NOVARTIS PHARMACEUTICAL CORPORATION | YR | F | Y | 20120330 | MD | CANADA |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8248776 | 1019282844 | PS | ZOLEDRONOC ACID | 1 | INTRAVENOUS | UNK | 021817 | ||||
| 8248776 | 1019282845 | SS | ZOLEDRONOC ACID | 1 | INTRAVENOUS | UNK | 021817 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 8248776 | 1019282844 | OSTEOPOROSIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 8248776 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 8248776 | ABASIA |
| 8248776 | APHAGIA |
| 8248776 | CEREBROVASCULAR ACCIDENT |
| 8248776 | DYSSTASIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 8248776 | 1019282844 | 20100513 | |||
| 8248776 | 1019282845 | 20110511 |